chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Borderline(Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (Borderline bodyache) and HEADACHE (Borderline headache). The patient was treated with PARACETAMOL (TYLENOL) on 01-Mar-2021 for Headache and General body pain, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) on 02-Mar-2021 for Headache and General body pain, at a dose of 1 dosage form. At the time of the report, PAIN (Borderline bodyache) outcome was unknown and HEADACHE (Borderline headache) had resolved.            Action taken with mRNA-1273 in response to the events was not Applicable.
Incredible shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 20-year male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration, in left arm on 17Mar2021 at 15:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included Ibuprofen once received for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 12:00, the patient experienced incredible shortness of breath. The adverse event resulted in emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of the event incredible shortness of breath was not recovered. Information about lot number cannot be obtained. No further information is expected.
esophageal acid reflux; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000003618 (Novavax).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GASTROOESOPHAGEAL REFLUX DISEASE (non-serious), outcome "unknown", described as "esophageal acid reflux".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever up to 102 degrees, severe body aches, uncontrollable shivering, lymphadenopathy, right arm pain
Noticed very high pitched ringing in both ears about 3.5 hours after injection. Ringing in both ears persists 22 hours after injection.
SORENESS; EXTREME FATIGUE; FEVER; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, once a total administered, therapy start date was not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced soreness, extreme fatigue, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the extreme fatigue, fever and soreness was not reported. This report was non-serious.
Severe chilling, temp of 101 orally, headache and body aches, nausea and vomiting x 2. Tylenol Extra Strength 500mgm 2 tablets every 6 hours x 2 doses
progressive weakness (new) (chronic) dyspepsia weakness began approx 21OCT; seen & adm to hosp 25OCT-weakness progressed further; dx GBS
Approx 3 hrs post 1st Hep B vax, became very sleepy; fell asleep for approx 1 1/2 hrs & awoke sl disoriented; very sleepy for the rest of day; next day devel a cold then strep throat;
pt comes to ED with c/o fever, chills, N/V, SOB and chest pain that comes and goes; was seen earlier in the week at a Clinic and had a COVID test, test is still pending; was given Phenergan; positive COVID test; in the ED was given O2 supplementation; began to have agonal respirations and required intubating; suffered cardiac arrest; ACLS; no ROSC obtained; pt died in the ED
likely had a heart attack; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (likely had a heart attack) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (likely had a heart attack). At the time of the report, CARDIAC DISORDER (likely had a heart attack) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medications details were not reported.  It was reported that the patient likely had a heart attack due to Moderna COVID-19 and Pfizer biotech COVID-19 vaccine.  No treatment information was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
The patient experienced 1 acute episode of chest pain lasting 5-10 minutes and described the pain as "crushing."  Afterward, the patient was hospitalized for 3 days.  A cardiologist diagnosed the pain as being due to stress.  The patient reported no prior history of heart problems or chest pain and consequently, experienced a very similar episode later on 6/4/03.  This case has already been reported.
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient' medical history, concurrent conditions and concomitant medication were unknown. On 18-OCT-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # M013156, expiration date 15-OCT-2017, 1 injection, intramuscular). No adverse reaction was reported. Additional information has been requested.
Body aches, fever, sore throat, persistent cough, dizziness, loss of voice, hives, right-sided chest pain for over 1 week
Pins and needles sensations all over the body; Lack of sleep due to symptoms; Pain on joints and muscle all over the body; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Pins and needles sensations all over the body), INSOMNIA (Lack of sleep due to symptoms), ARTHRALGIA (Pain on joints and muscle all over the body) and NAUSEA (Nausea) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included SALBUTAMOL (ALBUTEROL HFA), IPRATROPIUM and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PARAESTHESIA (Pins and needles sensations all over the body), INSOMNIA (Lack of sleep due to symptoms), ARTHRALGIA (Pain on joints and muscle all over the body) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Pins and needles sensations all over the body), INSOMNIA (Lack of sleep due to symptoms), ARTHRALGIA (Pain on joints and muscle all over the body) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
VAERS reporting as required by law, death occurred on 10/27/2021. Pfizer COVID 19 vaccine completed on 03/04/2021 and 03/25/2021.
The patient had two seizures in the car on the way home from the clinic approximately 35 minutes after receiving vaccine.
Patient felt very light headed, pale. patient given a drink of water, cold compress and moved to laying down on the floor. After 5 minutes   Patient requested paramedics to be called for evaluation. Patient was examined by paramedics and vials were all ok. This was approximately 15 minutes later. Then patient then went home with spouse.
Bad rash; A spontaneous report was received from a consumer concerning a female patient of an unknown age who received Modern'a Covid-19 vaccine (mRNA-1273) and developed a bad rash.  The patient's medical history was not provided. No concomitant medications were provided.   On an unspecified date, prior to onset of the event bad rash, the patient received their dose of mRNA-1273 (Lot/batch number: unknown) for prophylaxis of COVID-19 infection.   On an unspecified date, the patient experienced a bad rash. Not treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the event bad rash was not provided.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
High fever within several hours, post vax, of 103F-104F which lasted until the next day. Treated with fever reducer.
Lt deltoid sl edema, pain upon lifting arm, red blotchy below injection site. Hive like appearance.
I was an ER nurse in this hospital on the day of my adverse vaccine reaction. I was given the H1N1 vaccine by the employee health nurse and returned to the ER as a floor nurse. Exactly 15 minutes later, I collapsed on the floor and could not breathe. I was conscious while carried into a trauma room. EPI was used and zantac IV due to a sensitivity to solumedrol I had which causes suicidal thoughts. Even once treated and breathing again, hours later, I attempted to walk and collapsed on the floor a second time. Being myself the patient, I do not know if that was the full scope of all that occurred, but that is what I remember.  I realize today that I am probably only alive because I was already in the ER when this occurred. I have a history of anaphylaxis reactions to medicines, particularly at that time this had happened to benadryl in my past and to Septra, which both had to be treated urgently in ER. I believe my diagnosis at the time of this vaccine adverse event was anaphylaxis without respiratory failure.
Patient described that she developed cellulitis three days after receiving SHINGRIX dose 2. She reported that she had to go to urgent care to obtain antibiotics to cure the infection.
Received Moderna 2nd Injection on 03/31/2021 4:30pm - on 04/01/2021 I started having a fever, chills, joint pain, lower back pain, nausea this went on for 24 hours - I took Advil and Alieve to try and get some reiief from the pain.  The fever subsided.  However, the joint pain and back continued with nausea, it continued to increase day by day with me giving myself 800mg of Advil.  Nothing would touch the lower back pain -crippling to the point where I could not hardly walk.  (My legs would give) It was so unbearable that on 04/08/2021 I went to the ER.  The doctor felt I was having adverse side effects from the vaccine.  But to rule out everything else out there were numerous lab tests
This spontaneous report as received from an office supervisor  medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapies were not reported.  On unknown date in 2017, the patient was vaccinated with an incorrect storage dose of GARDASIL 9 lot # M036059, expiration date 03-JUN-2019, lot N002720, expiration date 12-MAY-2019 (dose and route were not reported) for prophylaxis. The vaccine was exposed from 47°F to 77°F for 12 hours. The vaccine was exposed from 32°F to 35°F for 1 hour. There was no previous temperature excursion. The call was made because there was a "data logger". No adverse effects were reported. No product quality complain was involved. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1707USA006643.
Developed hives 5min post receiving the vaccine. Treated with Benadryl.
Within 12 hours patient had redness and swelling in her left ankle was red and hot and swollen despite no injury and no unusual activity.  It was very hard to walk on it and quite painful.  She ended up seeing our office and podiatry and physical therapy and had an MRI.   Within a couple of weeks of that the redness and swelling settled down, but she developed dystonia and lost coordination of her gait--her leg would not move as expected as she was trying to walk and would unpredictably flex/spasm or relax and buckle at inappropriate intervals while walking.  Physical Therapy felt she had a neurologic rather than musculoskeletal etiology. By the end of April after therapy her dystonia begin to remit at times though again unpredictably.  Patient really has not been able to walk effectively and without pain since the day of the injection 4 months ago.
Rash, temp of 101 on evening of vax. L arm swollen, painful, pt hardly able to move. 11/11 L arm erythema & hard area at inject site, extending to lateral aspect of upper L arm. 11/12 hypotension. 11/13 pt returned to norm activities.
After a few minutes started feeling sluggish, pain in abdominal, ribs, bladder, not feeling well for x2 weeks. Cystitis flared up, gastroenteritis, auto immune worse. 2wks not feeling better went to MD and started on Augmented x4 days with no relief. Went to see holistic MD and prescribed herbs that helped.
A report has been received from a Pharmacist concerning a 7 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 27-Oct-2014. Patient received a small amount of FLUMIST in his eye which started on 27-Oct-2014. The outcome of the event of patient received a small amount of FLUMIST in his eye is unknown. The report was considered to be non-serious by the reporter.
arm soreness; sore throat; achy; joint pain; muscle pain; waves of nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), OROPHARYNGEAL PAIN (sore throat), PAIN (achy), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), OROPHARYNGEAL PAIN (sore throat), PAIN (achy), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and NAUSEA (waves of nausea). On 02-Feb-2021, PAIN IN EXTREMITY (arm soreness) had resolved. At the time of the report, OROPHARYNGEAL PAIN (sore throat), PAIN (achy), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and NAUSEA (waves of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication included.  Tylenol is used as treatment medication.
immediately after:  mild headache and nausea approximately 38 minutes after:  tightening of throat "I felt like I was wearing  a tie,"  3cm of hives on right hand, a little itchy all over.  States it resolved on its own within a few hours and he was able to go on with his day as normal.  States he has had more severe reactions to other things, like walking through grass.  Did take a benadryl later that night before bed.
Information has been received from a physician, concerning a 13 year old female with no pertinent medical history and no known allergies, who on 23-APR-2007 was vaccinated IM with the second dose, 0.5 ml, of Gardasil (lot # invalid).  Concomitant therapy included hormonal contraceptives (unspecified).  On 02-MAY-2007 the patient fainted while in the shower, and quickly recovered.  However, since that time, she has "fainted for several seconds, every few days."  The patient visited the physician's office, and an electrocardiogram (EKG) result was normal.  There were no other symptoms noted.  At the time of this report, the patient had not recovered.  Additional information has been requested.
Pt has previous hx of allergic reaction to covid vaccine. Cleared by PCP. Pt stayed for 30 min obs. During OBS pt began c/o an itchy throat and developed a cough.No s/s of distress. Increase face redness and slight hesitation in breathing.BP 160/110. Pt released to ED for further OBS.
Parsonage turner syndrome. Beginning 1-2 weeks following injection until present. Shoulder MRI/xrays negative. No injury. Severe right upper extremity neurologic pain. Radiation from trapezial region down to thumb with concentration in superior/anterior shoulder.
she has pain in her body/Her symptoms got worse; has shortness of breath still; joint pain; This is a spontaneous report from a non-contactable consumer (patient) reported for herself that an unknown age female patient received 1st dose of BNT162B2 (Pfizer COVID-19 Vaccine) on 08Apr2021 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. She has pain in her body. Her symptoms got worse. She has shortness of breath still and joint pain. She had to go to emergency room. She wants to know what issues will there be if she decides to not get second dose due to side effect she had with first dose. Outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Headache neck headache body aches low grade fever shakes chills lethargic sleepy very sore site interaction
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, INJECTION SITE PAIN, SWOLLEN GLANDS Narrative:
itchy; dizzy; stiff neck; watery eyes; no appetite; pain in ovaries or bladder; pain in ovaries or bladder; breathlessness; feels slightly frightened; headache/ back of head hurts/ got worse; feels aches all over body including hands/hurts in between shoulder blades; fever ranging from 101,102 to 104 degrees Fahrenheit; nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes) and DECREASED APPETITE (no appetite) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), DIZZINESS (dizzy), MUSCULOSKELETAL STIFFNESS (stiff neck), LACRIMATION INCREASED (watery eyes), DECREASED APPETITE (no appetite), BLADDER PAIN (pain in ovaries or bladder), ADNEXA UTERI PAIN (pain in ovaries or bladder), DYSPNOEA (breathlessness), FEAR (feels slightly frightened), HEADACHE (headache/ back of head hurts/ got worse), MYALGIA (feels aches all over body including hands/hurts in between shoulder blades), PYREXIA (fever ranging from 101,102 to 104 degrees Fahrenheit) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 101 °F (High) 101, 102 °F (High) 102 and 104 °F (High) 104.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported
7 month old received Moderna COVID-19 Vaccine Bivalent Booster, dark pink cap, 6m-5y
This case was reported by a physician via other manufacturer and described the occurrence of asthma in a 67-year-old female patient who received HAVRIX 1440 for prophylaxis. The patient had a Family History of coronary artery disease, diabetes mellitus, skin cancer, acute myocardial infarction (father died at 51) and stroke syndrome. Concurrent medical conditions included aldosteronism, angina pectoris (Angina Pectoris Prinzmetal's), anxiety disorder, bipolar disorder, carotid artery stenosis, chronic kidney disease (Stage 2), chronic obstructive pulmonary disease, congestive heart failure, fatty liver, fibromyalgia, gastroesophageal reflux disease, viral hepatitis c, hiatal hernia, hyperlipidemia, hypertension (systemic), hypokalemia, hypothyroidism, irritable bowel syndrome, migraine headache, obesity, osteoarthritis (Localized Primary Knee), Takotsubo syndrome, tremor, drug allergy (contrast dyes skin rashes and hives), latex allergy, allergic reaction to analgesics, insect bite allergy and sulfonamide allergy. Concomitant products included umeclidinium bromide, ANORO ELLIPTA, Aspirin, CRESTOR, buspirone hydrochloride, Calcium, carvedilol, Clindamycin Phosphate, clobetasol propionate, Hydroxyzine, lamotrigine, spironolactone, Levothyroxine Sodium, triamcinolone acetonide, nitroglycerine, NITROSTAT, cyanocobalamin, clonazepam, DEPLIN, DEXILANT, Dicyclomine Hydrochloride, FIBERCON, KLOR-CON, LASIZX, lisinopril, SEROQUEL and FETZIMA. On an unknown date, the patient received HAVRIX 1440 at an unknown dose. On an unknown date, unknown after receiving HAVRIX 1440, the patient experienced asthma, shortness of breath, rash, hives and airways obstruction. On an unknown date, the outcome of the asthma, shortness of breath, rash, hives and airways obstruction were unknown. It was unknown if the reporter considered the asthma, shortness of breath, rash, hives and airways obstruction to be related to HAVRIX 1440. Additional details were provided as follows: The age at vaccination was not reported. It was unknown if the patient had the allergies to Azithromycin, Tramadol HCl, SKALEXIN, LIPITOR or DEMEROL before or after vaccination with HAVRIX.